Edinburgh Research Explorer

Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling

Research output: Contribution to journalArticlepeer-review

  • Inma M Berenjeno
  • Roberto Piñeiro
  • Sandra D Castillo
  • Wayne Pearce
  • Nicholas McGranahan
  • Sally M Dewhurst
  • Valerie Meniel
  • Nicolai J Birkbak
  • Evelyn Lau
  • Laurent Sansregret
  • Daniele Morelli
  • Nnennaya Kanu
  • Shankar Srinivas
  • Mariona Graupera
  • Victoria E R Parker
  • Karen G Montgomery
  • Larissa S Moniz
  • Cheryl L Scudamore
  • Wayne A Phillips
  • Charles Swanton
  • Bart Vanhaesebroeck

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

    Final published version, 3.58 MB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

Original languageEnglish
Pages (from-to)1773
JournalNature Communications
Volume8
Issue number1
DOIs
Publication statusPublished - 24 Nov 2017

Abstract

Mutations in PIK3CA are very frequent in cancer and lead to sustained PI3K pathway activation. The impact of acute expression of mutant PIK3CA during early stages of malignancy is unknown. Using a mouse model to activate the Pik3ca H1047R hotspot mutation in the heterozygous state from its endogenous locus, we here report that mutant Pik3ca induces centrosome amplification in cultured cells (through a pathway involving AKT, ROCK and CDK2/Cyclin E-nucleophosmin) and in mouse tissues, and increased in vitro cellular tolerance to spontaneous genome doubling. We also present evidence that the majority of PIK3CA H1047R mutations in the TCGA breast cancer cohort precede genome doubling. These previously unappreciated roles of PIK3CA mutation show that PI3K signalling can contribute to the generation of irreversible genomic changes in cancer. While this can limit the impact of PI3K-targeted therapies, these findings also open the opportunity for therapeutic approaches aimed at limiting tumour heterogeneity and evolution.

    Research areas

  • Journal Article

Download statistics

No data available

ID: 47946387